Description
Semaglutide 5mg – Weekly GLP-1 Therapy for Weight Loss & Type 2 Diabetes
Semaglutide 5mg is a once-weekly injectable peptide designed to support effective weight management and improve blood sugar control in adults with type 2 diabetes. As a GLP-1 receptor agonist, Semaglutide mimics a natural hormone that regulates appetite, enhances insulin secretion, and helps lower blood glucose levels—providing a powerful tool for both metabolic and weight-related goals.
Key Benefits:
-
Aids in sustained weight loss when combined with healthy diet and lifestyle
-
Improves glycemic control in type 2 diabetes patients
-
Reduces hunger and caloric intake
-
Convenient once-weekly subcutaneous injection
Usage:
Administered once per week via subcutaneous injection, as directed by a licensed medical provider. Follow your healthcare provider’s guidelines for dosage and administration.
Important Note:
This medication is intended for use under medical supervision. It is not a substitute for proper diet, exercise, or lifestyle changes. Always consult your healthcare provider before beginning any new treatment.
⚠️ For Research Use Only. Not for Human Consumption.
This compound is sold strictly for in vitro laboratory research purposes only. It is not intended for human or veterinary use, nor for diagnostic or therapeutic purposes. No claims are made regarding safety or efficacy in any clinical application.Disclaimer:
All information provided is for educational and scientific reference only. Statements have not been evaluated by the FDA or any medical regulatory body. This product is not a drug or supplement. Buyer assumes all responsibility for lawful use and compliance with applicable regulations.Terms of Sale:
By purchasing from LIBERTY LABS, you confirm that you are a qualified researcher or institution equipped to handle this material safely. You accept full responsibility for its use and understand that Liberty Labs assumes no liability for misuse, misinterpretation, or improper application of this compound. ALL SALES FINAL